MOEXA
LIVE

Serial Number

99572306

Owner

Moexa Pharmaceuticals Limited

Attorney

Joseph G. Chu

Filing Date

Dec 30, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MOEXA Trademark

Serial Number: 99572306

MOEXA is a trademark filed by Moexa Pharmaceuticals Limited on December 30, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Moexa Pharmaceuticals Limited

Unit 1601, 16th Floor, Metropole Square
Shek Mun , HK

Entity Type: 99

Trademark Details

Filing Date

December 30, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment and prevention of cancer and fibrosis; Pharmaceutical preparations for medical purposes; Medical preparations for the treatment of cancer and fibrosis; Veterinary pharmaceutical preparations for the treatment of cancer and fibrosis; Medicaments for the treatment and prevention of cancer and fibrosis; Anti-cancer preparations; Medicaments for the treatment of cancer; Diagnostic agents, preparations and substances for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for preparations of therapeutic compounds for treatment, inhibition or prevention of cell proliferation, preparations and medicaments for therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Veterinary pharmaceutical preparations for the prevention of cancer and fibrosis; Pharmaceutical preparations for the prevention of cell proliferation; Pharmaceutical preparations for the prevention of cancer; Pharmaceutical preparations for the prevention of fibrosis; Medicaments for the prevention of fibrosis; Dietetic foods adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic pet foods adapted for veterinary use; Dietetic pet foods adapted for veterinary purposes; Dietary supplements for humans and animals; Pharmaceutical preparations for preparation of therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for preparation of therapeutic compounds for treatment, inhibition or prevention of cancer and fibrosis; Medicaments for the prevention of cell proliferation; Medicaments for the prevention of cancer

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 7, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 7, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 30, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2025 NWOS
NEW APPLICATION ENTERED
Dec 30, 2025 NWAP